Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
2.593
-0.057 (-2.15%)
Nov 21, 2024, 4:00 PM EST - Market closed

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
437233447
Upgrade
Market Cap Growth
0.20%-47.96%-71.05%-32.20%-28.18%213.03%
Upgrade
Enterprise Value
-3-11-14-83419
Upgrade
Last Close Price
2.593.1310.8441.60101.20219.20
Upgrade
PS Ratio
0.680.650.903.404.2440.53
Upgrade
PB Ratio
0.340.270.320.741.195.69
Upgrade
P/TBV Ratio
0.360.270.320.751.266.15
Upgrade
EV/Sales Ratio
----4.2416.57
Upgrade
Debt / Equity Ratio
0.030.080.100.110.330.27
Upgrade
Asset Turnover
0.270.220.200.150.200.04
Upgrade
Inventory Turnover
2.151.981.932.183.167.78
Upgrade
Quick Ratio
3.203.395.195.964.294.54
Upgrade
Current Ratio
4.604.176.037.025.024.98
Upgrade
Return on Equity (ROE)
-52.65%-78.36%-41.57%-54.01%-32.68%-273.15%
Upgrade
Return on Assets (ROA)
-38.72%-34.50%-24.24%-33.30%-26.92%-44.34%
Upgrade
Return on Capital (ROIC)
-55.18%-45.80%-30.76%-41.98%-44.39%-107.34%
Upgrade
Earnings Yield
-164.89%-402.29%-230.24%-63.54%-13.68%-60.79%
Upgrade
FCF Yield
-327.66%-440.21%-210.37%-116.49%-95.66%-39.41%
Upgrade
Buyback Yield / Dilution
-28.09%-106.37%-12.66%-113.68%-56.51%-68.94%
Upgrade
Total Shareholder Return
-28.09%-106.37%-12.66%-113.68%-56.51%-68.94%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.